Gurevičienė G. THE PHARMACOKINETICS, EFFICACY, IMMUNOGENICITY, AND SAFETY OF ATEZOLIZUMAB SUBCUTANEOUS IN NON-SMALL-CELL LUNG CANCER. IMSCIN001 CLINICAL STUDY (PART 2) [Internet]. PIA 2024 Sep.;8(2):214-218.[cited 2024 Oct. 28 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/1492